Efti Manufacturing Differences Shape Development Reset

Evidence Company disclosure · Discovery September 11, 2026 · Importance 5/5 · Direction Mixed Summary Immutep reported that its continuing review of the discontinued TACTI-004 Phase III trial has identified structural differences between eftilagimod alfa manufactured in 200-liter and 2,000-liter processes, including a subtle N-glycan…